Risperdal Gynecomastia Lawsuits
Risperdal gynecomastia lawsuits are currently being investigated by the nationally-respected attorneys from Kelley Bernheim Dolinsky, LLC on behalf of men who have developed excessive breast tissue as a side effect of this potentially dangerous drug. Risperdal was approved in 1993 for the treatment of schizophrenia, and has since become a popular treatment for other mental health disorders such as autism, OCD, ADHD, and Tourette Syndrome. Risperdal has proven to carry a number of serious side effects, but perhaps the most disturbing Risperdal side effect is gynecomastia, or the growth of breast tissue in men. At this time, our dangerous drug lawyers are helping men from across the United States pursue just compensation for their damages in Risperdal gynecomastia lawsuits.
What is Risperdal Gynecomastia?
Gynecomastia, male breast growth, is a troubling side effect of Risperdal. Many males who show early signs of gynecomastia as a Risperdal side effect assume that the increased breast volume is simply a consequence of medication-induced weight gain. Thus, they continue to use the drug and exacerbate the problem, which is much more difficult to fix as time goes on. Not only is the growth of breasts embarrassing and emotionally traumatic for males, but many men with Risperdal gynecomastia require liposuction or even mastectomy to eliminate the excess tissue.
Multiple respected studies have linked use of Risperdal to gynecomastia, or the growth of male breasts. Individuals who use Risperdal show an increase in levels of the hormone prolactin, which is responsible for breast development. A study published in the Journal of Clinical Psychopharmacology in 2006 concluded that regular doses of Risperdal “strongly increase prolactin levels, with clinical consequences such as gynecomastia.” A similar study published in 2009 supported this conclusion and found that patients who have taken Risperdal can show elevated prolactin levels for up to two years after discontinuing the medication.
Free Risperdal Gynecomastia Lawsuit Consultations
Risperdal is sold with the warning that the drug may cause gynecomastia, but many victims who have filed Risperdal gynecomastia lawsuits allege that the warnings do not adequately convey the likelihood of this side effect and that Johnson & Johnson willfully hid this information from the public and the medical community. In 2012, the first Risperdal gynecomastia lawsuit was settled on the first day of trials for an undisclosed amount, and multiple men across the United States have also filed dangerous drug lawsuits for compensation after Risperdal gynecomastia affected them. In addition to victims’ lawsuits, the US government has also charged Johnson & Johnson with illegally marketing Risperdal for off-label use in pediatric applications long before the FDA approved the drug for children. If you or a man in your life has suffered as a result of Risperdal gynecomastia or other side effects, you could be entitled to compensation for your damages. To learn more about Risperdal gynecomastia lawsuits, please contact our attorneys today for a free and confidential consultation.